EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Dietetic‐Led Cognitive‐Behavioral Therapy for Avoidant/Restrictive Food Intake Disorder: Feasibility, Acceptability, and Proof‐of‐Concept

Copeland G Winten iD, Esben Strodl iD, Gabriella Heruc iD, Joanne Avery iD, Kamryn T Eddy iD, Lynda J Ross iD, Jennifer J Thomas iD

International Journal of Eating Disorders · 2026

DOI: 10.1002/eat.70126 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Eating Disorders, 2026. Verfasst von Copeland G Winten und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Exercise and Nutrition Sciences, Queensland University of Technology, Kelvin Grove, Queensland, Australia. Hauptthemen laut MEDLINE: Cognitive Behavioral Therapy, Avoidant Restrictive Food Intake Disorder, Dietetics, Feeding and Eating Disorders. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIMH NIH HHS, Australian Government Research Training Program Scholarship, Rubenstein Charitable Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Cognitive‐Behavioral Therapy for Avoidant/Restrictive Food Intake Disorder (CBT‐AR) is an emerging treatment for ARFID, but to date, it has only been delivered by mental health clinicians. Given the relevance of nutrition to treatment goals, we adapted the treatment to be dietetic‐led (D‐CBT‐AR).

Method

We conducted a pilot trial of D‐CBT‐AR. Participants self‐referred to a multidisciplinary eating‐disorder clinic in Brisbane, Australia, and attended in person or virtually. Participants rated D‐CBT‐AR on acceptability and feasibility. We also measured changes in ARFID psychopathology, Body Mass Index, and co‐morbid psychopathology.

Results

Of the 12 participants offered D‐CBT‐AR, 92% ( n = 11) took up the treatment, and 72% ( n = 8) completed, with a median treatment length of 33 weeks. The majority of completers rated D‐CBT‐AR above benchmarks on feasibility (89%) and acceptability (78%). Using intent‐to‐treat analyses, participants reported large and significant improvements in ARFID psychopathology on all subscales of the Pica, ARFID and Rumination Disorder Interview. They incorporated a median of 26 new foods. For those who were weight‐suppressed, Body Mass Index increased by 1.5 bands from pre‐ to post‐treatment, though effects were non‐significant. Participants also reported large and significant reductions in clinical impairment, depression, and stress. Additionally, at 6‐months post‐treatment, five participants met remission criteria.

Discussion

The trial shows proof‐of‐concept for the feasibility and acceptability of D‐CBT‐AR. Although requiring replication in larger and randomized controlled trials, our findings highlight the potential of D‐CBT‐AR to expand the types of professionals who could effectively deliver CBT‐AR, thereby increasing access to care for individuals living with ARFID.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cognitive Behavioral TherapyAvoidant Restrictive Food Intake DisorderDieteticsFeeding and Eating DisordersHumansFemaleAdultFeasibility StudiesPilot ProjectsMaleMiddle AgedPatient Acceptance of Health CareProof of Concept StudyYoung AdultTreatment Outcome

Stichwörter der Autor:innen

avoidant/restrictive food intake disorder (ARFID)cognitive‐behavioral therapycognitive‐behavioral therapy for ARFID (CBT‐AR)dietitianeating disordersmalnutritionnutritionpsychopathology

Autor:innen und Institutionen

  • School of Exercise and Nutrition Sciences, Queensland University of Technology, Kelvin Grove, Queensland, Australia.
  • School of Psychology and Counselling, Queensland University of Technology, Kelvin Grove, Queensland, Australia.
  • Queensland University of Technology Eating Disorders Clinic, Kelvin Grove, Queensland, Australia.
  • Eating Disorders and Nutrition Research Group, Translational Health Research Institute, School of Medicine, Western Sydney University, New South Wales, Australia.
  • Eating Disorders Clinical and Research Program, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Copeland G Winten, Esben Strodl, Gabriella Heruc, Joanne Avery, Kamryn T Eddy, Lynda J Ross, Jennifer J Thomas

Förderung

  • NIMH NIH HHS
  • Australian Government Research Training Program Scholarship
  • Rubenstein Charitable Foundation
  • National Institute of Mental Health

Zitieren

APA

Winten, C. G., Strodl, E., Heruc, G., Avery, J., Eddy, K. T., Ross, L. J., & Thomas, J. J. (2026). Dietetic‐Led Cognitive‐Behavioral Therapy for Avoidant/Restrictive Food Intake Disorder: Feasibility, Acceptability, and Proof‐of‐Concept. International Journal of Eating Disorders. https://doi.org/10.1002/eat.70126

Vancouver

Winten CG, Strodl E, Heruc G, Avery J, Eddy KT, Ross LJ, et al. Dietetic‐Led Cognitive‐Behavioral Therapy for Avoidant/Restrictive Food Intake Disorder: Feasibility, Acceptability, and Proof‐of‐Concept. International Journal of Eating Disorders. 2026. doi:10.1002/eat.70126

BibTeX
@article{Winten2026,
  author = {Winten, Copeland G and Strodl, Esben and Heruc, Gabriella and Avery, Joanne and Eddy, Kamryn T and Ross, Lynda J and Thomas, Jennifer J},
  title = {Dietetic‐Led Cognitive‐Behavioral Therapy for Avoidant/Restrictive Food Intake Disorder: Feasibility, Acceptability, and Proof‐of‐Concept},
  journal = {International Journal of Eating Disorders},
  year = {2026},
  doi = {10.1002/eat.70126}
}
Kostenlos starten →